Kuantitas, Kualitas, dan Daya Fagositosis Neutrofil pada Saliva dan Darah Bayi Baru Lahir dengan Faktor Risiko Sepsis

Authors

  • Ari Yunanto Laboratorium Ilmu Kesehatan Anak Fakultas Kedokteran Universitas Lambung Mangkurat Banjarmasin
  • MS Chandra Laboratorium Ilmu Kesehatan Anak Fakultas Kedokteran Universitas Brawijaya Malang
  • Edi Widjajanto Laboratorium Patologi Klinik Fakultas Kedokteran Universitas Brawijaya Malang
  • M Aris Widodo Laboratorium Farmakologi Fakultas Kedokteran Universitas Brawijaya Malang

DOI:

https://doi.org/10.21776/ub.jkb.2012.027.02.7

Abstract


Sepsis neonatal adalah  sindrom klinik pada bulan pertama kehidupan bayi akibat  respons  sistemik  terhadap  infeksi.   Analisis saliva menjadi sumber daya penting untuk mengevaluasi kondisi saliva pada  implikasi keadaan  fisiologis dan patologis,  yang berguna sebagai sarana untuk diagnosis penyakit. Neutrofil merupakan merupakan sel yang pertama kali datang di lokasi inflamasi dan merupakan komponen seluler utama untuk respon natural selama infeksi akut, influks ke saliva  terjadi  terus-menerus. Tujuan dari penelitian  ini adalah untuk mengetahui kualitas dan kuantitas neutrofil saliva dan darah bayi baru lahir dengan risiko sepsis. Sebanyak 30 sampel dari saliva dan darah bayi dengan risiko sepsis diambil sebagai kasus serta 30 sampel saliva dan darah bayi sehat sebagai kontrol. Terdapat perbedaan yang bermakna antara jumlah neutrofil, daya fagositosis (30 menit dan 60 menit), ekspresi TLR2 & TLR4, myeloperoksidase (MPO), H2O2, dan laktoferin (LTF) pada saliva dan darah bayi kasus dibandingkan dengan saliva dan darah bayi kontrol. Hasil menunjukkan neutrofil saliva dapat digunakan sebagai salah satu biomarker adanya sepsis neonatal awitan dini.

Kata Kunci: Fagositosis, H O LTF, MPO, neutrofil, sepsis neonatal, TLR2, TLR4 2 2,

Downloads

Download data is not yet available.

References

Haque K. Management of Bacterial Infection on the Newborn. Journal Arab Neonatal Forum. 2006; 3: 41-45.

Bizzaro JM, Raskind C, Baltimore RS, and Gallagher PG. Seventy-Five Years of Sepsis At Yale: 1928-2003. Pediatrics. 2005; 116 (3): 595-602.

Quinn MT and Gauss KA. Structure and Regulation of the Neutrophi l Respiratory Burst Oxidase: Comparison with Nonphagocyte Oxidases. Journal of Leukocyte Biology. 2004; 76(4): 760-781.

Ashby MT. Inorganic Chemistry of Defensive Peroxidase in the Human Oral Cavity. Journal of Dental Research. 2008; 87(10): 900-914.

Gasparoto TH, Vieira NA, Porto VC, Campanelli AP, and Lara VS. Ageing Exacerbates Damage of Systemic and Salivary Neutrophils from Patients Presenting Candida-Related Denture Stomatitis. Immunity and Ageing. 2009; 6 (3): 1-12.

Aminullah A. Sepsis pada Bayi Baru Lahir – Masalah dan Penatalaksanaannya. Proceeding Simposium Nasional Ikatan Dokter Anak Indonesia Cabang Kalimantan Selatan. Banjarmasin, 2005; hal. 68-86.

Urlichs F and Speer CP. Neutrophil Function in Preterm and Term Infants. NeoReviews. 2004; 5(10): 417-430.

Papayannopoulos V and Zychlinsky A. NETs: A New Strategy for Using Old Weapons. Trends in Immunology. 2009; 30 (11): 513-521.

Bhandari V, Wang C, Rinder C, and Rinder H. Hematologic Profile of Sepsis in Neonates: Neutrophil CD64 as a Diagnostic Marker. Pediatrics. 2008; 121 (1): 129-134.

Viemann D, Dubbel G, Schleifenbaum S, Harms E, Sorg C, and Roth J. Expression of Toll-Like Receptor in Neonatal Sepsis. Pediatric Research. 2005; 58(4): 654-659.

Halfhide CP, Brearey SP, Flanagan BF, et al. Neutrophil TLR4 Expression is Reduced in the Airways of Infants with Severe Bronchiolitis. Thorax. 2009; 64(9): 798-805.

Djojohusodo D. Ekspresi Toll Like Receptor 2,4 Sebagai Petanda Dini Infeksi Perinatal Pada Bayi Berat Lahir Rendah Sesuai Masa Kehamilan. [Disertasi]. Universitas Brawijaya, Malang. 2012.

Samaranayake LP. Is Saliva the Magic Diagnostic Fluid We were Waiting for? The Saudi Dental Journal. 2009; 20(3): 109-110.

Lima DP, Diniz DG, Sumida DH, Moimaz SA, and Okamoto AC. Saliva: Reflection of the Body. International Journal of Infectious Desease. 2010; 14(3): e184–e188.

, Kumar S, Savadi RC, and John J. Nanodentistry: A Paradigm Shift-From Fiction to Reality. Journal of Indian Prosthodontic Society. 2011; 11(1): 1-6.

Ogawa K, Furukawa S, Fujita S, et al. Inhibition of Streptococcus Mutans Biofilm Formation by Streptococcus Sal ivarius Frua. Appl ied and Environmental Microbiology. 2011; 77(5): 1572-1580.

Wong DT. Salivary Diagnostiks Powered by Nanotechnologies, Proteomics and Genomics. The Journal of the American Dental Association. 2006; 137: 313-321.

Markopoulos AK, Michailidou EZ, and Tzimagiorgis G. Salivary Markers for Oral Cancer Detection. The Open Dentistry Journal. 2010; 4: 172-178.

Pink R, Simek J, Vondrokova J, et al. Saliva as a Diagnostic Medium. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic. 2009; 153(2): 103-110.Kumar PS

William DL, Ha T, Li C, et al. Modulation of Tissue Tol-Like Receptor 2 And 4 during the Early Phases of Polymicrobial Sepsis Correlates with Mortality. Critical Care Medicine. 2003; 31(6): 1808-1818.

Tsujimoto H, Ono S, Efron PA, Scumpia PO, Moldawer LL, and Mochizuki H. Role of Toll-Like Receptors in the Development of Sepsis. Shock. 2008; 29(3): 315-321.

Vrba J and Modriansky M. Respiratory Burst Of Kupffer Cells: Target for Liver Injury Treatment. Biomedical Papers. 2002; 146 (2): 15-20.

Toumi H, F'guyer S, and Best TM. The Role of Neutrophils in Injury and Repair Following Muscle Stretch. Journal of Anatomy 2006; 208: 459-470.

Klebanoff SJ. Myeloperoxidase: Friend or Foe. Journal of Leukocyte Biology. 2005; 77(5): 598-625.

Brock JH. The Physiology of Lactoferrin. Biochemistry and Cell Biology. 2002; 80(1): 1–6.

Kruzel ML, Actor JK, Boldogh I, and Zimecki M. Lactoferrin in Health and Disease. Postępy Higieny i Medycyny Doświadczalnej. 2007; 61: 261-267.

Downloads

Published

2013-02-13

Issue

Vol. 27 No. 2 (2012)

Section

Research Article

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

Most read articles by the same author(s)

1 2 3 > >>